Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bone marrow mononuclear cell delivery in advanced limb ischemia
NL-OMON22349Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Jan 2004
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Randomised, open-label trial of bone marrow mononuclear cells in peripheral artery occlusion (PAD) and limb ischemia (2 arms), sponsored by Leiden University Medical Center. Primary endpoints: Wound healing / limb salvage, Pain-free walking distance and 2 more. Started Jan 2004; status: active, not recruiting.
02
Drugs
bone marrow mononuclear cells
03
Conditions
peripheral artery occlusion (PAD)limb ischemia
Beyond the preview
Go deeper on NL-OMON22349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON22349.